Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04257448
Title Safety and Tolerance of Epigenetic and Immunomodulating Drugs Combined With Chemotherapeutics in Patients Suffering From Advanced Pancreatic Cancer (SEPION)
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors GWT-TUD GmbH

pancreatic ductal adenocarcinoma


Gemcitabine + Nab-paclitaxel + Romidepsin

Azacitidine + Gemcitabine + Nab-paclitaxel

Azacitidine + Gemcitabine + Nab-paclitaxel + Romidepsin

Gemcitabine + Nab-paclitaxel

Durvalumab + Lenalidomide

Age Groups: senior | adult
Covered Countries DEU

No variant requirements are available.